pyroglutamyl-glutamyl-prolyl amide (UCLA)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepyroglutamyl-glutamyl-prolyl amide (UCLA)
Drug Alias Nametri-peptide (UCLA)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California, Los Angeles
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A